有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N,N-bis(2-cyanoethyl)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C12H14N4OS2 |
|
—— | 4-amino-3-[(1S)-cyclohex-2-en-1-yl]sulfanyl-6-methyl-1,2,4-triazin-5-one | —— | C10H14N4OS |
|
—— | 4-amino-3-[(1R)-cyclohex-2-en-1-yl]sulfanyl-6-methyl-1,2,4-triazin-5-one | —— | C10H14N4OS |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanenitrile | —— | C11H8BrN3OS |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C12H15N3OS2 |
|
—— | Tert-butyl 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C14H15BrN2O3S |
|
—— | 2-Benzylsulfanyl-5-(2-bromophenyl)-1,3,4-oxadiazole | —— | C15H11BrN2OS |
|
—— | 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1R)-1-cyano-1-cyclopropylethyl]acetamide | —— | C16H15BrN4O2S |
|
—— | (2S)-N-[2-(1-methylimidazol-2-yl)sulfanylphenyl]-2-(1,3,5-trimethylpyrazol-4-yl)propanamide | —— | C19H23N5OS |
|
—— | (2R)-N-[2-(1-methylimidazol-2-yl)sulfanylphenyl]-2-(1,3,5-trimethylpyrazol-4-yl)propanamide | —— | C19H23N5OS |
|
—— | 1-[(3R)-3-(furan-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]ethanone | —— | C20H19N3O2S2 |
|
—— | 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-cyanoethyl)-N-methylacetamide | —— | C14H13BrN4O2S |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(methylcarbamoyl)propanamide | —— | C13H13BrN4O3S |
|
—— | N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C14H22N2OS2 |
|
—— | 2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-propan-2-ylacetamide | —— | C9H14N2OS2 |
|
—— | (2S)-N-(furan-2-ylmethyl)-2-(1,3,4-thiadiazol-2-ylsulfanyl)propanamide | —— | C10H11N3O2S2 |
|
—— | 1-[(3R)-5-(4-chlorophenyl)-3-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)ethanone | —— | C17H13ClN4O2S2 |
|
—— | (2R)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]propanamide | —— | C7H10N2OS2 |
|
—— | 2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C16H20N2OS2 |
|
—— | [(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylpropyl]azanium | —— | C13H17FN3OS+ |
|
—— | (2R)-N-[(2-cyclopentyloxypyridin-3-yl)methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C20H22N2O3S |
|
—— | (2S)-N-[(2-cyclopentyloxypyridin-3-yl)methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C20H22N2O3S |
|
—— | (2R)-N-[[4-(4-fluorophenyl)oxan-4-yl]methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C21H22FNO3S |
|
—— | (2S)-N-[[4-(4-fluorophenyl)oxan-4-yl]methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C21H22FNO3S |
|
—— | 1-[(9aS)-1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl]-3-(2-bromophenyl)sulfanylpropan-1-one | —— | C17H23BrN2OS |
|
—— | 1-[(9aR)-1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl]-3-(2-bromophenyl)sulfanylpropan-1-one | —— | C17H23BrN2OS |
|
—— | 2-Ethylsulfanyl-5-[(3-fluorophenyl)methyl]-3,6-dimethylpyrimidin-4-one | —— | C15H17FN2OS |
|
—— | 2-[(3,4-difluorobenzyl)sulfanyl]-3,6-dimethyl-5-(2-methylbenzyl)-4(3H)-pyrimidinone | —— | C21H20F2N2OS |
|
—— | [(1S,2R)-1-(5-benzylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylbutyl]azanium | —— | C14H20N3OS+ |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(1S)-1-phenylbutyl]acetamide | —— | C21H24N4OS2 |
|
—— | 3,3-Dimethyl-6-methylsulfanyl-8-morpholin-4-yl-1,4-dihydrothiopyrano[3,4-c]pyridin-7-ium-5-carbonitrile | —— | C16H22N3OS2+ |
|
—— | [(6S)-4-[6-amino-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-yl]-1,4-oxazepan-6-yl]methanol | —— | C18H24N4O2S |
|
—— | [(6R)-4-[6-amino-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-yl]-1,4-oxazepan-6-yl]methanol | —— | C18H24N4O2S |
|
—— | 2-(3-cyano-4,5,6-trimethylpyridin-2-yl)sulfanyl-N-(thiophen-2-ylmethyl)acetamide | —— | C16H17N3OS2 |
|
—— | 2-[(2-Chloro-6-fluorophenyl)methylsulfanyl]-4,5,6-trimethylpyridine-3-carbonitrile | —— | C16H14ClFN2S |
|
—— | ethyl 5-[(2R)-2-(3-cyano-4,5,6-trimethylpyridin-2-yl)sulfanylpropanoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C21H25N3O3S |
|
—— | 2-[(1S)-1-(2-chlorophenyl)ethyl]sulfanyl-4,5,6-trimethylpyridine-3-carbonitrile | —— | C17H17ClN2S |
|
—— | N-[(2S)-butan-2-yl]-2-(3-cyano-4,5,6-trimethylpyridin-2-yl)sulfanylacetamide | —— | C15H21N3OS |
|
—— | 2-[(4-Fluorophenyl)methylsulfanyl]-4,5,6-trimethylpyridine-3-carbonitrile | —— | C16H15FN2S |
|
—— | N-(1-cyanocyclopentyl)-2-(3-cyano-4,5,6-trimethylpyridin-2-yl)sulfanylacetamide | —— | C17H20N4OS |
|
—— | N-(2-benzylsulfanylethyl)-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C14H17N3OS3 |
|
—— | N-(2-benzylsulfanylethyl)-2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H21N3O2S2 |
|
—— | N-(cyclohexen-1-yl)-N-(furan-2-ylmethyl)-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C22H23N3O3S |
|
—— | 2-[5-[2-(4,6-Diaminopyrimidin-2-yl)sulfanylacetyl]thiophen-2-yl]-1-morpholin-4-ylethanone | —— | C16H19N5O3S2 |
|
—— | N-(2-benzylsulfanylethyl)-2-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C19H22N4O2S2 |
|
—— | 2-[(4-amino-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-(cyclohexen-1-yl)-N-(furan-2-ylmethyl)acetamide | —— | C19H21N5O2S2 |
|
—— | N-(cyclohexen-1-yl)-N-(furan-2-ylmethyl)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C21H21N3O3S |
|
—— | [2-(Cyclohexylamino)-2-oxoethyl] 2-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetate | —— | C18H28N4O3S2 |
|
—— | [(2S)-1-amino-1-oxopropan-2-yl] 2-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetate | —— | C13H20N4O3S2 |
|
—— | (3,5-Dimethyl-1,2-oxazol-4-yl)methyl 2-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetate | —— | C16H22N4O3S2 |
|